Effects of Guanfacine Extended Release on Secondary Measures in Children With Attention-Deficit/Hyperactivity Disorder and Oppositional Symptoms

被引:0
|
作者
Sallee, Floyd [1 ]
Spencer, Thomas [2 ]
Connor, Daniel [3 ]
Lopez, Frank [4 ]
Lyne, Andrew [5 ]
Tremblay, Gerald [6 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Clin & Res Program Pediat Psychopharmacol, Boston, MA USA
[3] Univ Connecticut, Sch Med, Farmington, CT USA
[4] Childrens Dev Ctr, Winter Pk, FL USA
[5] Shire Pharmaceut Dev Ltd, Global Biomet, Basingstoke, Hants, England
[6] Shire Dev Inc, Neurosci, Wayne, PA USA
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
488
引用
收藏
页码:149S / 149S
页数:1
相关论文
共 50 条
  • [31] DIAGNOSTIC EFFICIENCY OF SYMPTOMS FOR OPPOSITIONAL DEFIANT DISORDER AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    WALDMAN, ID
    LILIENFELD, SO
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1991, 59 (05) : 732 - 738
  • [32] Efficacy of Guanfacine Extended Release in the Treatment of Combined and Inattentive Only Subtypes of Attention-Deficit/Hyperactivity Disorder
    Sallee, Floyd R.
    Kollins, Scott H.
    Wigal, Timothy L.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2012, 22 (03) : 206 - 214
  • [33] The distribution of symptoms of attention-deficit/hyperactivity disorder and oppositional defiant disorder in school age children in Turkey
    Ersan, EE
    Dogan, O
    Dogan, S
    Sümer, H
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2004, 13 (06) : 354 - 361
  • [34] The distribution of symptoms of attention-deficit/hyperactivity disorder and oppositional defiant disorder in school age children in Turkey
    E. Erdal Erşan
    Orhan Doğan
    Selma Doğan
    Haldun Sümer
    [J]. European Child & Adolescent Psychiatry, 2004, 13 : 354 - 361
  • [35] Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder
    Erder, M.
    Xie, Jipan
    Signorovitch, James
    Chen, Kristina
    Hodgkins, Paul
    Lu, Mei
    Wu, Eric
    Sikirica, Vanja
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2012, 10 (06) : 381 - 395
  • [36] A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder
    Wilens, Timothy E.
    Robertson, Brigitte
    Sikirica, Vanja
    Harper, Linda
    Young, Joel L.
    Bloomfield, Ralph
    Lyne, Andrew
    Rynkowski, Gail
    Cutler, Andrew J.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2015, 54 (11): : 916 - 925
  • [37] Impact on the family of children with attention-deficit/hyperactivity disorder, oppositional defiant disorder
    Hull, BS
    Robin, AL
    Doyal, GT
    [J]. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 1997, 18 (05): : 366 - 366
  • [38] Extended-release medications for children and adolescents with attention-deficit hyperactivity disorder
    Feldman, M.
    Belanger, S.
    [J]. PAEDIATRICS & CHILD HEALTH, 2009, 14 (09) : 593 - 596
  • [39] Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder
    Silva, Raul R.
    Muniz, Rafael
    Pestreich, Linda
    Brams, Matthew
    Mao, Alice R.
    Childress, Ann
    Wang, James
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2008, 47 (02): : 199 - 208
  • [40] GUANFACINE FOR TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN BOYS
    HORRIGAN, JP
    BARNHILL, LJ
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 1995, 5 (03) : 215 - 223